Share Price and Basic Stock Data
Last Updated: December 15, 2025, 3:36 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alchemist Corporation Ltd operates within the chemicals sector, specifically focusing on inorganic chemicals. As of the latest reporting period, the company’s stock price stood at ₹26.3, with a market capitalization of ₹12.9 Cr. Notably, the company has reported no sales since March 2023, consistently recording ₹0.00 across all recent quarters, indicating a significant operational stagnation. Historical sales figures show a peak of ₹0.46 Cr in March 2021, followed by a drastic decline to ₹0.00, reflecting serious challenges in revenue generation. The absence of sales raises concerns about the company’s ability to sustain operations and invest in future growth. The trend of zero revenue is alarming and suggests that the company may be facing severe market or operational issues that require immediate attention. The lack of operational income over multiple quarters also raises questions about the company’s business model and strategic direction.
Profitability and Efficiency Metrics
Profitability metrics for Alchemist Corporation reveal a troubling financial landscape. The company reported a net profit of -₹0.28 Cr, with a negative trend in earnings per share (EPS), which declined to -₹0.57 in March 2025. Operating losses have persisted, with the operating profit margin (OPM) remaining negative. The interest coverage ratio stood at -3.08x, indicating that the company is unable to cover its interest expenses, further complicating its financial stability. Return on equity (ROE) was recorded at 9.02%, which is relatively low, and return on capital employed (ROCE) stood at 7.45%, both of which reflect inefficiencies in utilizing shareholders’ funds. While the company has historically generated some income from other sources, the overall trend shows that profitability remains elusive, necessitating a reevaluation of operational strategies and cost management to achieve sustainable financial health.
Balance Sheet Strength and Financial Ratios
The balance sheet of Alchemist Corporation reveals significant vulnerabilities. The company reported reserves of -₹4.48 Cr as of March 2025, indicating a negative equity position that poses a risk to financial stability. With borrowings recorded at ₹0.00 Cr, the company is free from debt, which is a positive aspect; however, the absence of reserves raises concerns about liquidity and the ability to fund operations or investments. The current ratio stood at 1.72, suggesting that current assets exceed current liabilities, which is favorable for short-term solvency. However, the total debt to equity ratio of 1.28 indicates a high level of leverage when considering total liabilities, including other obligations. The price-to-book value ratio is at 10.18x, which is significantly higher than typical sector ranges, suggesting that the stock may be overvalued given the company’s financial performance.
Shareholding Pattern and Investor Confidence
Alchemist Corporation’s shareholding pattern indicates a strong promoter commitment, with promoters holding a substantial 74.11% of the equity as of March 2025. This concentrated ownership may provide some stability; however, the public shareholding stands at 25.88%, which is relatively low and could limit liquidity in the stock. The number of shareholders has fluctuated, peaking at 1,745 in March 2024 but declining to 1,601 in September 2025. This decline in shareholder numbers could reflect waning investor confidence amid the company’s operational challenges and stagnant revenue. The absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) further highlights a lack of institutional interest, which is crucial for enhancing market perception and liquidity. To regain investor confidence, the company must demonstrate a clear path to operational recovery and profitability.
Outlook, Risks, and Final Insight
The outlook for Alchemist Corporation remains precarious, primarily due to the ongoing lack of revenue and profitability. The operational stagnation poses significant risks, including potential insolvency if conditions do not improve. Key strengths include a debt-free balance sheet, which provides some operational flexibility, and a committed promoter group that may be willing to support the company through its challenges. However, the risks associated with negative reserves, poor profitability metrics, and declining investor confidence cannot be overlooked. For the company to recover, it must implement strategic changes to its business model, enhance operational efficiency, and actively pursue new revenue streams. A successful turnaround could restore investor interest and stabilize the company’s financial position, but failure to act may lead to further deterioration and potential bankruptcy.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,607 Cr. | 40.2 | 125/39.1 | 130 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 15.0 Cr. | 29.9 | 45.9/25.8 | 65.0 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 211 Cr. | 269 | 356/238 | 12.6 | 211 | 2.98 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,369 Cr. | 516 | 728/408 | 31.1 | 157 | 0.58 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 336 Cr. | 430 | 503/376 | 16.4 | 144 | 0.70 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,679.00 Cr | 377.42 | 148.78 | 156.25 | 0.50% | 13.95% | 10.65% | 6.18 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.03 | 0.03 | 0.09 | 0.04 | 0.04 | 0.04 | 0.12 | 0.05 | 0.09 | 0.05 | 1.14 | 0.05 | 0.05 |
| Operating Profit | -0.03 | -0.03 | -0.09 | -0.04 | -0.04 | -0.04 | -0.12 | -0.05 | -0.09 | -0.05 | -1.14 | -0.05 | -0.05 |
| OPM % | |||||||||||||
| Other Income | 0.03 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | 0.03 | 0.03 | 0.03 | 1.03 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | -0.09 | -0.09 | -0.04 | -0.07 | -0.06 | 0.29 | -0.04 | -0.08 | -0.03 | -0.13 | -0.05 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 17.24% | 0.00% | 0.00% | 0.00% | 0.00% | 60.00% | 0.00% | |
| Net Profit | 0.00 | -0.09 | -0.09 | -0.04 | -0.07 | -0.06 | 0.24 | -0.04 | -0.08 | -0.03 | -0.13 | -0.07 | -0.05 |
| EPS in Rs | 0.00 | -0.18 | -0.18 | -0.08 | -0.14 | -0.12 | 0.49 | -0.08 | -0.16 | -0.06 | -0.28 | -0.14 | -0.10 |
Last Updated: December 28, 2025, 6:31 am
Below is a detailed analysis of the quarterly data for Alchemist Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.05 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.05 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded -0.05 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.05 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded -0.05 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 60.00% (Jun 2025) to 0.00%, marking a decrease of 60.00%.
- For Net Profit, as of Sep 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -0.07 Cr. (Jun 2025) to -0.05 Cr., marking an increase of 0.02 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.10. The value appears strong and on an upward trend. It has increased from -0.14 (Jun 2025) to -0.10, marking an increase of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:16 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.34 | 0.00 | 0.40 | 0.34 | 0.34 | 0.46 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.12 | 0.10 | 0.60 | 0.28 | 1.66 | 0.27 | 0.29 | 0.31 | 0.24 | 0.18 | 0.24 | 1.31 | 1.29 |
| Operating Profit | -0.12 | -0.10 | -0.26 | -0.28 | -1.26 | 0.07 | 0.05 | 0.15 | -0.19 | -0.18 | -0.24 | -1.31 | -1.29 |
| OPM % | -76.47% | -315.00% | 20.59% | 14.71% | 32.61% | -380.00% | |||||||
| Other Income | -0.07 | -0.02 | 0.03 | -0.38 | 1.30 | 0.01 | 0.00 | -2.04 | -1.42 | 0.00 | 0.43 | 1.11 | 1.06 |
| Interest | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.07 | 0.03 |
| Depreciation | 0.01 | 0.02 | 0.01 | 0.01 | 0.04 | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.21 | -0.15 | -0.25 | -0.67 | -0.01 | 0.05 | 0.02 | -1.92 | -1.62 | -0.18 | 0.12 | -0.27 | -0.26 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | 50.00% | 0.00% | 0.00% | 0.00% | 41.67% | 0.00% | |
| Net Profit | -0.21 | -0.14 | -0.25 | -0.67 | 0.00 | 0.04 | 0.02 | -1.91 | -1.62 | -0.18 | 0.07 | -0.27 | -0.28 |
| EPS in Rs | -0.43 | -0.28 | -0.51 | -1.36 | 0.00 | 0.08 | 0.04 | -3.89 | -3.30 | -0.37 | 0.14 | -0.57 | -0.58 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 33.33% | -78.57% | -168.00% | 100.00% | -50.00% | -9650.00% | 15.18% | 88.89% | 138.89% | -485.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -111.90% | -89.43% | 268.00% | -150.00% | -9600.00% | 9665.18% | 73.71% | 50.00% | -624.60% |
Alchemist Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -19% |
| TTM: | -557% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 29% |
| 3 Years: | 35% |
| 1 Year: | 71% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -1% |
| 3 Years: | -1% |
| Last Year: | -3% |
Last Updated: September 5, 2025, 2:11 pm
Balance Sheet
Last Updated: December 4, 2025, 2:20 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 |
| Reserves | 15.29 | 15.11 | 14.84 | 14.16 | 14.17 | 14.22 | 14.25 | 12.34 | 10.72 | 10.54 | 10.95 | -4.36 | -4.48 |
| Borrowings | 0.00 | 0.00 | 0.39 | 0.39 | 0.38 | 0.38 | 0.38 | 0.31 | 0.21 | 0.55 | 0.60 | 0.71 | 0.00 |
| Other Liabilities | 6.89 | 5.61 | 5.68 | 2.57 | 1.71 | 1.75 | 1.68 | 1.79 | 1.63 | 1.61 | 1.34 | 0.07 | 0.19 |
| Total Liabilities | 27.09 | 25.63 | 25.82 | 22.03 | 21.17 | 21.26 | 21.22 | 19.35 | 17.47 | 17.61 | 17.80 | 1.33 | 0.62 |
| Fixed Assets | 15.19 | 15.15 | 15.11 | 15.08 | 15.05 | 15.02 | 14.99 | 14.96 | 14.76 | 14.76 | 14.76 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.78 | 4.78 | 4.78 | 2.98 | 2.98 | 2.98 | 2.98 | 2.98 | 1.27 | 1.27 | 1.61 | 0.02 | 0.02 |
| Other Assets | 7.12 | 5.70 | 5.93 | 3.97 | 3.14 | 3.26 | 3.25 | 1.41 | 1.44 | 1.58 | 1.43 | 1.31 | 0.60 |
| Total Assets | 27.09 | 25.63 | 25.82 | 22.03 | 21.17 | 21.26 | 21.22 | 19.35 | 17.47 | 17.61 | 17.80 | 1.33 | 0.62 |
Below is a detailed analysis of the balance sheet data for Alchemist Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.91 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.91 Cr..
- For Reserves, as of Sep 2025, the value is -4.48 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -4.36 Cr. (Mar 2025) to -4.48 Cr., marking a decline of 0.12 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 0.71 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.71 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.07 Cr. (Mar 2025) to 0.19 Cr., marking an increase of 0.12 Cr..
- For Total Liabilities, as of Sep 2025, the value is 0.62 Cr.. The value appears to be improving (decreasing). It has decreased from 1.33 Cr. (Mar 2025) to 0.62 Cr., marking a decrease of 0.71 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Other Assets, as of Sep 2025, the value is 0.60 Cr.. The value appears to be declining and may need further review. It has decreased from 1.31 Cr. (Mar 2025) to 0.60 Cr., marking a decrease of 0.71 Cr..
- For Total Assets, as of Sep 2025, the value is 0.62 Cr.. The value appears to be declining and may need further review. It has decreased from 1.33 Cr. (Mar 2025) to 0.62 Cr., marking a decrease of 0.71 Cr..
However, the Borrowings (0.00 Cr.) are higher than the Reserves (-4.48 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.12 | -0.10 | -0.65 | -0.67 | -1.64 | -0.31 | -0.33 | -0.16 | -0.40 | -0.73 | -0.84 | -2.02 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4,573.24 | 2,162.62 | 2,544.26 | 2,254.41 | 0.00 | 0.00 | ||||||
| Inventory Days | 1,233.11 | 0.00 | ||||||||||
| Days Payable | 4,281.35 | |||||||||||
| Cash Conversion Cycle | 1,524.99 | 2,162.62 | 2,544.26 | 2,254.41 | 0.00 | 0.00 | ||||||
| Working Capital Days | 128.82 | 1,213.62 | 1,545.88 | 1,610.29 | -372.93 | -1,825.00 | ||||||
| ROCE % | -0.64% | -0.55% | -1.19% | -1.31% | 0.00% | 0.26% | 0.10% | 0.65% | -1.14% | -1.13% | 1.17% | -2.25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.57 | 0.13 | -0.37 | -3.29 | -3.89 |
| Diluted EPS (Rs.) | -0.57 | 0.13 | -0.37 | -3.29 | -3.89 |
| Cash EPS (Rs.) | -0.54 | 0.13 | -0.36 | -3.27 | -3.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.13 | 2.39 | 1.56 | 1.93 | 4.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.13 | 32.28 | 31.45 | 31.82 | 35.11 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.11 | 0.93 |
| PBDIT / Share (Rs.) | -0.41 | 0.36 | -0.36 | 0.22 | 0.31 |
| PBIT / Share (Rs.) | -0.41 | 0.36 | -0.36 | 0.19 | 0.26 |
| PBT / Share (Rs.) | -0.54 | 0.23 | -0.36 | -3.29 | -3.90 |
| Net Profit / Share (Rs.) | -0.54 | 0.13 | -0.36 | -3.29 | -3.89 |
| NP After MI And SOA / Share (Rs.) | -0.56 | 0.13 | -0.36 | -3.29 | -3.89 |
| PBDIT Margin (%) | 0.00 | 0.00 | -12020.00 | 191.22 | 33.58 |
| PBIT Margin (%) | 0.00 | 0.00 | -12020.00 | 172.28 | 28.07 |
| PBT Margin (%) | 0.00 | 0.00 | -12073.33 | -2835.96 | -419.48 |
| Net Profit Margin (%) | 0.00 | 0.00 | -12073.33 | -2834.38 | -418.47 |
| NP After MI And SOA Margin (%) | 0.00 | 0.00 | -11973.33 | -2834.03 | -418.06 |
| Return on Networth / Equity (%) | -49.90 | 5.61 | -23.42 | -170.72 | -81.97 |
| Return on Capital Employeed (%) | -36.01 | 1.13 | -1.16 | 0.61 | 0.73 |
| Return On Assets (%) | -20.94 | 0.37 | -1.01 | -9.25 | -9.88 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.06 | 0.21 | 0.13 |
| Total Debt / Equity (X) | 1.28 | 0.50 | 0.06 | 0.21 | 0.13 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Current Ratio (X) | 1.72 | 0.73 | 0.71 | 0.84 | 0.74 |
| Quick Ratio (X) | 1.72 | 0.73 | 0.71 | 0.84 | 0.74 |
| Interest Coverage Ratio (X) | -3.08 | 2.75 | -225.38 | 30.28 | 56.89 |
| Interest Coverage Ratio (Post Tax) (X) | -3.08 | 1.98 | -225.38 | 27.53 | 49.26 |
| Enterprise Value (Cr.) | 6.36 | 8.40 | 8.44 | 8.17 | 2.87 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 5623.62 | 143.28 | 6.28 |
| EV / EBITDA (X) | -31.35 | 46.45 | -46.79 | 74.92 | 18.70 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 5618.68 | 139.67 | 5.64 |
| Price / BV (X) | 10.18 | 6.64 | 11.00 | 8.42 | 1.11 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 5716.67 | 140.87 | 5.65 |
| EarningsYield | -0.04 | 0.01 | -0.02 | -0.20 | -0.74 |
After reviewing the key financial ratios for Alchemist Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to -0.57, marking a decrease of 0.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to -0.57, marking a decrease of 0.70.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 3. It has decreased from 0.13 (Mar 24) to -0.54, marking a decrease of 0.67.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.13. It has decreased from 2.39 (Mar 24) to 1.13, marking a decrease of 1.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.13. It has decreased from 32.28 (Mar 24) to 1.13, marking a decrease of 31.15.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has decreased from 0.36 (Mar 24) to -0.41, marking a decrease of 0.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 0. It has decreased from 0.36 (Mar 24) to -0.41, marking a decrease of 0.77.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 0. It has decreased from 0.23 (Mar 24) to -0.54, marking a decrease of 0.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 2. It has decreased from 0.13 (Mar 24) to -0.54, marking a decrease of 0.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 2. It has decreased from 0.13 (Mar 24) to -0.56, marking a decrease of 0.69.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 8. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is -49.90. This value is below the healthy minimum of 15. It has decreased from 5.61 (Mar 24) to -49.90, marking a decrease of 55.51.
- For Return on Capital Employeed (%), as of Mar 25, the value is -36.01. This value is below the healthy minimum of 10. It has decreased from 1.13 (Mar 24) to -36.01, marking a decrease of 37.14.
- For Return On Assets (%), as of Mar 25, the value is -20.94. This value is below the healthy minimum of 5. It has decreased from 0.37 (Mar 24) to -20.94, marking a decrease of 21.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.28. This value exceeds the healthy maximum of 1. It has increased from 0.50 (Mar 24) to 1.28, marking an increase of 0.78.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.72, marking an increase of 0.99.
- For Quick Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.72, marking an increase of 0.99.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 3. It has decreased from 2.75 (Mar 24) to -3.08, marking a decrease of 5.83.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 3. It has decreased from 1.98 (Mar 24) to -3.08, marking a decrease of 5.06.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6.36. It has decreased from 8.40 (Mar 24) to 6.36, marking a decrease of 2.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EV / EBITDA (X), as of Mar 25, the value is -31.35. This value is below the healthy minimum of 5. It has decreased from 46.45 (Mar 24) to -31.35, marking a decrease of 77.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 10.18. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 10.18, marking an increase of 3.54.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.04, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alchemist Corporation Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -36.01% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -49.9% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -3.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 148.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.28
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
Fundamental Analysis of Alchemist Corporation Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | R-4, Unit No. 103, First Floor, New Delhi Delhi 110017 | info@alchemist-corp.com http://www.alchemist-corp.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Pooja Rastogi | Managing Director |
| Mr. Kailash | Independent Director |
| Mrs. Meena Rastogi | Non Executive Director |
| Mrs. Sheetal Jain | Non Executive Director |
| Mr. Sanjeev Kumar | Independent Director |
Alchemist Corporation Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹15.11 |
| Previous Day | ₹15.11 |
FAQ
What is the intrinsic value of Alchemist Corporation Ltd?
Alchemist Corporation Ltd's intrinsic value (as of 11 January 2026) is ₹0.96 which is 96.35% lower the current market price of ₹26.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹12.9 Cr. market cap, FY2025-2026 high/low of ₹26.3/10.5, reserves of ₹-4.48 Cr, and liabilities of ₹0.62 Cr.
What is the Market Cap of Alchemist Corporation Ltd?
The Market Cap of Alchemist Corporation Ltd is 12.9 Cr..
What is the current Stock Price of Alchemist Corporation Ltd as on 11 January 2026?
The current stock price of Alchemist Corporation Ltd as on 11 January 2026 is ₹26.3.
What is the High / Low of Alchemist Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alchemist Corporation Ltd stocks is ₹26.3/10.5.
What is the Stock P/E of Alchemist Corporation Ltd?
The Stock P/E of Alchemist Corporation Ltd is .
What is the Book Value of Alchemist Corporation Ltd?
The Book Value of Alchemist Corporation Ltd is 0.87.
What is the Dividend Yield of Alchemist Corporation Ltd?
The Dividend Yield of Alchemist Corporation Ltd is 0.00 %.
What is the ROCE of Alchemist Corporation Ltd?
The ROCE of Alchemist Corporation Ltd is 7.45 %.
What is the ROE of Alchemist Corporation Ltd?
The ROE of Alchemist Corporation Ltd is 9.02 %.
What is the Face Value of Alchemist Corporation Ltd?
The Face Value of Alchemist Corporation Ltd is 10.0.